Awarded contract

Laboratory reagents

Details

Supplier(s)
Curium
Topic
Laboratory reagents
Published
10 April 2019

Tender description

Royal Marsden Hospital needs to purchase of ANMI PSMA Setrile 360 vials and ANMI Elution Tools Gen A to treat prostate cancer. The Royal Marsden Hospital requires purchase of ANMI PSMA Setrile 360 VIALS and ANMI Elution Tools Gen A to treat prostate cancer. ANMI PSMA Setrile 360 Vials and ANMI Elution Tools Gen A is the only viable kit for imaging of prostate cancer in UK PMSA-11 is the most specific peptide-chelator available for diagnosis of prostate cancer. No other available treatment as effective are available on the NHS – Ga-68 PSMA scan can be used in PET imaging. PET imaging provides greater resolution and speed of imaging and therefore diagnosis of prostate cancer.

Timeline

  1. Completed: Award published10 April 2019
    Current notice
  2. Completed: Award date10 April 2019

About the buyer

The Royal Marsden NHS Foundation Trusts is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 33696500 · Laboratory reagents

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.